News articles about Synopsys (NASDAQ:SNPS) have been trending positive on Wednesday, according to Accern Sentiment. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Synopsys earned a news impact score of 0.26 on Accern’s scale. Accern also assigned news headlines about the semiconductor company an impact score of 47.4962297999011 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Here are some of the news headlines that may have impacted Accern Sentiment’s rankings:
Shares of Synopsys (SNPS) traded up $1.12 on Wednesday, hitting $86.62. The stock had a trading volume of 1,292,451 shares, compared to its average volume of 990,956. Synopsys has a 1 year low of $65.56 and a 1 year high of $94.80. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $12,689.74, a P/E ratio of 101.91, a price-to-earnings-growth ratio of 3.80 and a beta of 1.04.
Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, November 29th. The semiconductor company reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.12. Synopsys had a return on equity of 5.78% and a net margin of 5.01%. The firm had revenue of $696.60 million for the quarter, compared to the consensus estimate of $650.72 million. During the same quarter in the prior year, the business earned $0.77 earnings per share. The company’s revenue was up 9.9% compared to the same quarter last year. equities research analysts expect that Synopsys will post 2.24 EPS for the current fiscal year.
Several analysts have weighed in on SNPS shares. BidaskClub upgraded Synopsys from a “hold” rating to a “buy” rating in a research note on Tuesday, January 23rd. Needham & Company LLC boosted their price target on Synopsys from $83.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, December 1st. DA Davidson reiterated a “buy” rating and set a $105.00 price target (up previously from $91.00) on shares of Synopsys in a research note on Tuesday, November 28th. Royal Bank of Canada reiterated a “buy” rating and set a $120.00 price target on shares of Synopsys in a research note on Thursday, November 30th. Finally, TheStreet downgraded Synopsys from an “a” rating to a “c+” rating in a research note on Wednesday, November 29th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $96.89.
In other Synopsys news, Director Steven Walske sold 4,545 shares of the stock in a transaction that occurred on Wednesday, January 17th. The stock was sold at an average price of $90.12, for a total transaction of $409,595.40. Following the transaction, the director now owns 14,988 shares in the company, valued at $1,350,718.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Chrysostomos L. Nikias sold 21,074 shares of the stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $89.78, for a total value of $1,892,023.72. The disclosure for this sale can be found here. Insiders have sold 65,442 shares of company stock worth $5,779,693 in the last quarter. 1.82% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Favorable Media Coverage Somewhat Unlikely to Impact Synopsys (SNPS) Share Price” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/favorable-media-coverage-somewhat-unlikely-to-impact-synopsys-snps-share-price.html.
Synopsys Company Profile
Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.